Presentation TCT 2016 Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative? Presenter: Hendrik Treede October 30, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Aortic Valve Up Next Presentation TCT 2016 Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip) Presenter: Marco Barbanti October 30, 2016 More slides + Presentation TCT 2016 The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials Presenter: Mayank Yadav October 30, 2016 Presentation TCT 2016 TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples) Presenter: Mathew Williams October 30, 2016 We Recommend
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip) Presenter: Marco Barbanti October 30, 2016
Presentation TCT 2016 The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials Presenter: Mayank Yadav October 30, 2016
Presentation TCT 2016 TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples) Presenter: Mathew Williams October 30, 2016